Therapeutic Asset Ratings

303 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Yb-1 Lung Cancer	University of Washington	P2	CCC (53)
FES F-18 Breast Cancer	University of Washington	P3	CCC (52)
Loncastuximab Tesirine Mantle Cell Lymphoma	University of Washington	P2	CCC (52)
Pirtobrutinib Follicular Lymphoma	University of Washington	P2	CCC (52)
Fedratinib Myelodysplastic Syndrome	University of Washington	P2	CCC (51)
Golimumab Prostate Adenocarcinoma	University of Washington	P2	CCC (51)
mln9708 Marginal Zone Lymphoma	University of Washington	P2	CCC (51)
Odronextamab Relapsed/Refractory Diffuse Large B-Cell Lymphoma	University of Washington	P2	CCC (51)
Pacritinib Myelodysplastic Syndrome	University of Washington	P2	CCC (51)
Pacritinib Myelofibrosis	University of Washington	P2	CCC (51)
VIPIVOTIDE TETRAXETAN GALLIUM GA-68 Castration-Resistant Prostate Carcinoma	University of Washington	P2	CCC (51)
Cladribine Mixed Phenotype Acute Leukemia	University of Washington	P1/2	CCC (51)
Dostarlimab Breast Cancer	University of Washington	P2	CCC (50)
mln9708 Follicular Lymphoma	University of Washington	P2	CCC (50)
Pumvc3-Higfbp-2 Multi-Epitope Plasmid Dna Vaccine Fallopian Tube Carcinoma	University of Washington	P2	CCC (50)
Pumvc3-Higfbp-2 Multi-Epitope Plasmid Dna Vaccine Primary Peritoneal Carcinoma	University of Washington	P2	CCC (50)
mln9708 Chronic Lymphocytic Leukemia	University of Washington	P2	CCC (48)
Recombinant Human Granulocyte Colony-Stimulating Factor Myeloid Sarcoma	University of Washington	P1/2	CCC (48)
Bomedemstat Small Cell Lung Carcinoma	University of Washington	P1/2	CC (47)
FLUDEOXYGLUCOSE Follicular Lymphoma	University of Washington	P1/2	CC (47)
Recombinant Human Granulocyte Colony-Stimulating Factor Acute Biphenotypic Leukemia	University of Washington	P1/2	CC (47)
Retifanlimab High Grade B-Cell Lymphoma	University of Washington	P1/2	CC (47)
Fedratinib Acute Myeloid Leukemia	University of Washington	P2	CC (46)
Pacritinib Essential Thrombocythemia	University of Washington	P2	CC (46)
Pacritinib Myelodysplastic/Myeloproliferative Neoplasm	University of Washington	P2	CC (46)

Showing 226 to 250 of 303 assets

PreviousPage 10 of 13Next